Glutamatergic drugs exacerbate symptomatic behavior in a transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder

Brain Research

Volumn 877, Issue 1, 2000, Pages 23-30

  McGrath, Michael J ^a   Campbell, Keith M ^a   Parks III, Clinton R ^a   Burton, Frank H ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Glutamate; Obsessive compulsive; Seizure; Tourette's syndrome; Transgenic; Trichotillomania

Indexed keywords

6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; CHOLERA TOXIN; DIZOCILPINE; GLUTAMATE RECEPTOR; GLUTAMIC ACID;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; GILLES DE LA TOURETTE SYNDROME; MALE; MOUSE; NONHUMAN; OBSESSION; PRIORITY JOURNAL; RECEPTOR BINDING; STEREOTYPY; TRANSGENIC MOUSE;

ANIMALS; CEREBRAL CORTEX; COMORBIDITY; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; LIMBIC SYSTEM; MALE; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; MOTOR ACTIVITY; OBSESSIVE-COMPULSIVE DISORDER; QUINOXALINES; SEIZURES; TOURETTE SYNDROME;

EID: 0034665830     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02646-9     Document Type: Article

References (30)

1. Breiter H.C., Rauch S.L. Functional MRI and the study of OCD: from symptom provocation to cognitive-behavioral probes of cortico-striatal systems and the amygdala. Neuroimage. 4:1996;S127-138.
2. Breiter H.C., Rauch S.L., Kwong K.K., Baker J.R., Weisskoff R.M., Kennedy D.N., Kendrick A.D., Davis T.L., Jiang A., Cohen M.S., Stern C.E., Belliveau J.W., Baer L., O'Sullivan R.L., Savage C.R., Jenike M.A., Rosen B.R. Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch. Gen. Psychiatry. 53:1996;595-606.
3. Burton F.H., Hasel K.W., Bloom F.E., Sutcliffe J.G. Pituitary hyperplasia and gigantism in mice caused by a cholera toxin transgene. Nature. 350:1991;74-77.
4. Campbell K.M., de Lecea L., Severynse D.M., Caron M.G., McGrath M.J., Sparber S.B., Sun L.Y., Burton F.H. OCD-Like behaviors caused by a neuropotentiating transgene targeted to cortical and limbic D1+ neurons. J. Neurosci. 19:1999;5044-5053.
5. Campbell K.M., McGrath M.J., Burton F.H. Behavioral effects of cocaine on a transgenic mouse model of cortical-limbic compulsion. Brain Res. 833:1999;216-224.
6. Campbell K.M., McGrath M.J., Burton F.H. Differential response of cortical-limbic neuropotentiated compulsive mice to dopamine D1 and D2 receptor antagonists. Eur. J. Pharmacol. 371:1999;103-111.
7. Campbell K.M., Rohland R.M., McGrath M.J., Satoskar S.D., Burton F.H. Detecting subtle differences in behavior using waveform display analysis. Physiol. Behav. 64:1998;83-91.
8. Deutsch S.I., Hitri A. Measurement of an explosive behavior in the mouse, induced by MK-801, a PCP analogue. Clin. Neuropharmacol. 16:1993;251-257.
9. Frankel M., Cummings J.L., Robertson M.M., Trimble M.R., Hill M.A., Benson D.F. Obsessions and compulsions in Gilles de la Tourette's syndrome. Neurology. 36:1986;378-382.
10. Fray P.J., Sahakian B.J., Robbins T.W., Koob G.F., Iversen S.D. An observational method for quantifying the behavioural effects of dopamine agonists: contrasting effects of d-amphetamine and apomorphine. Psychopharmacology (Berl.). 69:1980;253-259.
11. Gerfen C.R. The Basal Ganglia. Handbook of Chemical Neuroanatomy. Vol. 12:1996;371-468.
12. Hitri A., O'Connor D.A., Cohen J.M., Keuler D.J., Deutsch S.I. Differentiation between MK-801- and apomorphine-induced stereotyped behaviors in mice. Clin. Neuropharmacol. 16:1993;220-236.
13. Hughes P., Young D., Dragunow M. MK-801 sensitizes rats to pilocarpine induced limbic seizures and status epilepticus. NeuroReport. 4:1993;314-316.
14. Jackson A., Mead A.N., Rocha B.A., Stephens D.N. AMPA receptors and motivation for drug: effect of the selective antagonist NBQX on behavioural sensitization and on self-administration in mice. Behav. Pharmacol. 9:1998;457-467.
15. Jenike M.A. Neurosurgical treatment of obsessive-compulsive disorder [see comments]. Br. J. Psychiatry Suppl. 1:1998;79-90.
16. Kurlan R., Kersun J., Ballantine H.T. Jr., Caine E.D. Neurosurgical treatment of severe obsessive-compulsive disorder associated with Tourette's syndrome. Mov. Disord. 5:1990;152-155.
17. Leonard H.L., Lenane M.C., Swedo S.E., Rettew D.C., Gershon E.S., Rapoport J.L. Tics and Tourette's disorder: a 2- to 7-year follow-up of 54 obsessive-compulsive children. Am. J. Psychiatry. 149:1992;1244-1251.
18. Loscher W. Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy. Prog. Neurobiol. 54:1998;721-741.
19. Meldrum B.S. The role of glutamate in epilepsy and other CNS disorders. Neurology. 44:1994;S14-23.
20. Moghaddam B., Adams B.W. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats [see comments]. Science. 281:1998;1349-1352.
21. Nee L.E., Caine E.D., Polinsky R.J., Eldridge R., Ebert M.H. Gilles de la Tourette syndrome: clinical and family study of 50 cases. Ann. Neurol. 7:1980;41-49.
22. Rapoport J.L., Swedo S.E., Leonard H.L. Childhood obsessive compulsive disorder. J. Clin. Psychiatry. 53:1992;11-16.
23. Rosen J.B., Davis M. Enhancement of acoustic startle by electrical stimulation of the amygdala. Behav. Neurosci. 102:1988;195-202. see also p. 324.
24. Sheppard D.M., Bradshaw J.L., Purcell R., Pantelis C. Tourette's and comorbid syndromes: obsessive compulsive and attention deficit hyperactivity disorder. A common etiology? Clin. Psychol. Rev. 19:1999;531-552.
25. Standaert D.G., Landwehrmeyer G.B., Kerner J.A., Penney J.B. Jr., Young A.B. Expression of NMDAR2D glutamate receptor subunit mRNA in neurochemically identified interneurons in the rat neostriatum, neocortex and hippocampus. Mol. Brain Res. 42:1996;89-102.
26. Swedberg M.D., Jacobsen P., Honore T. Anticonvulsant, anxiolytic and discriminative effects of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline (NBQX). J. Pharmacol. Exp. Ther. 274:1995;1113-1121.
27. Turski L., Ikonomidou C., Turski W.A., Bortolotto Z.A., Cavalheiro E.A. Review: cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: a novel experimental model of intractable epilepsy. Synapse. 3:1989;154-171.
28. Young D., Dragunow M. Non-NMDA glutamate receptors are involved in the maintenance of status epilepticus. NeuroReport. 5:1993;81-83.
29. Zeiger M.A., Saji M., Gusev Y., Westra W.H., Takiyama Y., Dooley W.C., Kohn L.D., Levine M.A. Thyroid-specific expression of cholera toxin A1 subunit causes thyroid hyperplasia and hyperthyroidism in transgenic mice. Endocrinology. 138:1997;3133-3140.
30. Zhang X., Gelowitz D.L., Lai C.T., Boulton A.A., Yu P.H. Gradation of kainic acid-induced rat limbic seizures and expression of hippocampal heat shock protein-70. Eur. J. Neurosci. 9:1997;760-769.